USP9X and Sepsis: In a sepsis-induced AKI model, USP9x inhibits the ubiquitinated degradation of toll-like receptor 4 (TLR4), which is involved in inflammatory responses and apoptosis by activating the NF-κB signaling pathway through interaction with lipopolysaccharide (LPS).